Jardiance: new “flozin” now available for type 2 diabetesThird SGLT2 inhibitor in Canada reduces cardiovascular risk in Canadian-led clinical trial. Alberta children not meeting recommended daily intake of vitamin DLess than one-quarter meet the recommended dietary allowance for vitamin D through diet and supplements. New cloud-based diabetes self-care system announced by Philips Pharmacists enhance screening for diabetes in patients on atypical antipsychotics Intervention by pharmacists increases adherence to antipsychotic–diabetes screening guidelines. Saxenda: new option for chronic weight management Higher-dose liraglutide product intended as an adjunct to diet and increased physical activity. Clinical Feature: Confronting diabetes challenges Practical strategies to optimize care and outcomes in diabetes management. Drugmakers: Diabetes medicine Jardiance first to show prevention of heart complications, death First evidence a drug reduces risk of complications that are the top killer of diabetes patients. U.S.: Adopted parents suing doctors for gender reassignment surgery on intersex infant Canadian Diabetes Association issues 2015 interim diabetes guidelines update Incorporates data on sodium-glucose linked transporter 2 (SGLT2) inhibitors for type 2 diabetes. Toronto researchers alleged to have falsified data; ask court to review claims Retraction of two scientific papers, concerns about a third led to allegations. First Previous 115 116 117 118 119 Next Last
